Scientists say new tests and treatments are “a game changer” – Newsweek
The big potential benefit, say Alzheimer’s experts, lies in using these drugs, or others soon to come, in conjunction with a second recent development in the field: diagnostic blood tests that can identify the presence of Alzheimer’s-associated proteins. With more than a dozen different blood tests currently undergoing clinical trials, scientists believe that in a few years clinicians may be able to use them to make quick, early diagnoses cheaply, even before patients show any outward symptoms of dementia

New drugs for dementia will require early diagnosis and comprehensive treatment
LikeLike